SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

MYGN Expands Cancer Test

Myriad Genetics expands availability of Precise MRD for colorectal, renal, and breast cancers

MYGN

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.